Cerenis Therapeutics Holding SA (CEREN) - Financial and Strategic SWOT Analysis Review

  • ID: 4284802
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Cerenis Therapeutics Holding SA (Cerenis) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. The company is developing a portfolio of HDL therapies for the rapid regression of atherosclerotic plaque in high-risk patients such as patients with HDL deficiency, and post-ACS patients. It is also developing drugs that increase HDL for patients with low number of HDL particles to treat atherosclerosis and related metabolic diseases. The company works with various other research and biotechnology companies to develop medicinal products. Cerenis is headquartered in Labege, France.

Cerenis Therapeutics Holding SA Key Recent Developments

Feb 01, 2018: Cerenis Therapeutics: 2017 Annual Results And Update On Tango
Jan 25, 2018: CERENIS Therapeutics: Cash position and activity update for Q4 2017
Oct 26, 2017: Cerenis Therapeutics: Cash Position and Activity Update for Q3 2017
Jul 20, 2017: Cerenis Therapeutics: Cash Position and Activity Update for H1 2017
Apr 20, 2017: Cerenis Therapeutics : Cash position and update on clinical developments for Q1 2017

This comprehensive SWOT profile of Cerenis Therapeutics Holding SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cerenis Therapeutics Holding SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Cerenis Therapeutics Holding SA - Key Information
  • Cerenis Therapeutics Holding SA - Overview
  • Cerenis Therapeutics Holding SA - Key Employees
  • Cerenis Therapeutics Holding SA - Key Employee Biographies
  • Cerenis Therapeutics Holding SA - Key Operational Heads
  • Cerenis Therapeutics Holding SA - Major Products and Services
  • Cerenis Therapeutics Holding SA - History
  • Cerenis Therapeutics Holding SA - Company Statement
  • Cerenis Therapeutics Holding SA - Locations And Subsidiaries
  • Cerenis Therapeutics Holding SA - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Cerenis Therapeutics Holding SA - Business Description
  • Cerenis Therapeutics Holding SA - Corporate Strategy
  • Cerenis Therapeutics Holding SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Cerenis Therapeutics Holding SA - Strengths
  • Cerenis Therapeutics Holding SA - Weaknesses
  • Cerenis Therapeutics Holding SA - Opportunities
  • Cerenis Therapeutics Holding SA - Threats
  • Cerenis Therapeutics Holding SA - Key Competitors
Section 3 - Company Financial Performance Charts
  • Cerenis Therapeutics Holding SA - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Cerenis Therapeutics Holding SA, Key Information
  • Cerenis Therapeutics Holding SA, Key Ratios
  • Cerenis Therapeutics Holding SA, Share Data
  • Cerenis Therapeutics Holding SA, Major Products and Services
  • Cerenis Therapeutics Holding SA, History
  • Cerenis Therapeutics Holding SA, Key Employees
  • Cerenis Therapeutics Holding SA, Key Employee Biographies
  • Cerenis Therapeutics Holding SA, Key Operational Heads
  • Cerenis Therapeutics Holding SA, Other Locations
  • Cerenis Therapeutics Holding SA, Subsidiaries
  • Cerenis Therapeutics Holding SA, Key Manufacturing facilities
  • Cerenis Therapeutics Holding SA, Key Competitors
  • Cerenis Therapeutics Holding SA, SWOT Analysis
  • Cerenis Therapeutics Holding SA, Ratios based on current share price
  • Cerenis Therapeutics Holding SA, Annual Ratios
  • Cerenis Therapeutics Holding SA, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Cerenis Therapeutics Holding SA, Performance Chart
  • Cerenis Therapeutics Holding SA, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll